Distinct GBM cell lines exhibit differences in metabolic profiles due to variations in isocitrate dehydrogenase (IDH1) expression [33] and in other factors, such as epidermal growth factor receptor (EGFR) [34]. This evidence concerns the gene EGFR and glioblastoma.